

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.38693794 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.38693794 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.37324490 |
| 4 | exogenous drug catabolic process (GO:0042738) | 7.32343606 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.06385849 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.06385849 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.59839575 |
| 8 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 6.50600401 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 6.48195658 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.38891237 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.90039222 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.90039222 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.90039222 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.82195524 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.77998379 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.70191227 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68688474 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.67595015 |
| 19 | tryptophan metabolic process (GO:0006568) | 5.57104725 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.55982276 |
| 21 | urea metabolic process (GO:0019627) | 5.46756943 |
| 22 | urea cycle (GO:0000050) | 5.46756943 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.46397901 |
| 24 | cysteine metabolic process (GO:0006534) | 5.33993648 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.24833833 |
| 26 | protein carboxylation (GO:0018214) | 5.18153961 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18153961 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.04289842 |
| 29 | bile acid metabolic process (GO:0008206) | 5.04263651 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.03573910 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.03561543 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.03067292 |
| 33 | phenylpropanoid metabolic process (GO:0009698) | 4.96091643 |
| 34 | ethanol metabolic process (GO:0006067) | 4.91702839 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.91091208 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.87976298 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.87399331 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.82770486 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.79577512 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.78289226 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.76565508 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.76565508 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76565508 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.71086793 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 4.71086793 |
| 46 | oxidative demethylation (GO:0070989) | 4.69203344 |
| 47 | regulation of complement activation (GO:0030449) | 4.68017411 |
| 48 | tyrosine metabolic process (GO:0006570) | 4.67359294 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.66771276 |
| 50 | phospholipid efflux (GO:0033700) | 4.65913305 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.64601653 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.64601653 |
| 53 | bile acid and bile salt transport (GO:0015721) | 4.58838267 |
| 54 | cellular glucuronidation (GO:0052695) | 4.55498803 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.55273695 |
| 56 | lysine catabolic process (GO:0006554) | 4.51583180 |
| 57 | lysine metabolic process (GO:0006553) | 4.51583180 |
| 58 | regulation of plasminogen activation (GO:0010755) | 4.51442721 |
| 59 | negative regulation of hemostasis (GO:1900047) | 4.35123222 |
| 60 | negative regulation of blood coagulation (GO:0030195) | 4.35123222 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.34936821 |
| 62 | * cellular ketone body metabolic process (GO:0046950) | 4.33115617 |
| 63 | glycine metabolic process (GO:0006544) | 4.26204634 |
| 64 | flavonoid metabolic process (GO:0009812) | 4.25730594 |
| 65 | cellular amino acid catabolic process (GO:0009063) | 4.25001862 |
| 66 | ethanol oxidation (GO:0006069) | 4.23033791 |
| 67 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 4.19349249 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.18753260 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.17601970 |
| 70 | cholesterol efflux (GO:0033344) | 4.16793946 |
| 71 | coenzyme catabolic process (GO:0009109) | 4.16739873 |
| 72 | glutamate metabolic process (GO:0006536) | 4.12561113 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.09220263 |
| 74 | amine catabolic process (GO:0009310) | 4.09220263 |
| 75 | benzene-containing compound metabolic process (GO:0042537) | 4.07980413 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.06668023 |
| 77 | uronic acid metabolic process (GO:0006063) | 4.05878970 |
| 78 | glucuronate metabolic process (GO:0019585) | 4.05878970 |
| 79 | aldehyde catabolic process (GO:0046185) | 4.05328572 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 4.03972234 |
| 81 | intestinal cholesterol absorption (GO:0030299) | 4.01900231 |
| 82 | negative regulation of protein activation cascade (GO:2000258) | 4.00906360 |
| 83 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00470510 |
| 84 | negative regulation of coagulation (GO:0050819) | 3.99270508 |
| 85 | heme transport (GO:0015886) | 3.99028373 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 3.95237430 |
| 87 | protein-lipid complex subunit organization (GO:0071825) | 3.94963653 |
| 88 | drug catabolic process (GO:0042737) | 3.92733792 |
| 89 | serine family amino acid biosynthetic process (GO:0009070) | 3.92517827 |
| 90 | arginine metabolic process (GO:0006525) | 3.91237574 |
| 91 | negative regulation of wound healing (GO:0061045) | 3.88858021 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.88252008 |
| 93 | fibrinolysis (GO:0042730) | 3.87482710 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 3.80917579 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.79022297 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.78265165 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.78265165 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.77669738 |
| 99 | organic acid catabolic process (GO:0016054) | 3.77569569 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.77569569 |
| 101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77173433 |
| 102 | S-adenosylmethionine metabolic process (GO:0046500) | 3.77101010 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.76283255 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.75733993 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.74789657 |
| 106 | regulation of humoral immune response (GO:0002920) | 3.74256083 |
| 107 | sterol homeostasis (GO:0055092) | 3.71455562 |
| 108 | negative regulation of lipase activity (GO:0060192) | 3.70931733 |
| 109 | alkaloid metabolic process (GO:0009820) | 3.70518981 |
| 110 | complement activation (GO:0006956) | 3.69694514 |
| 111 | regulation of cholesterol homeostasis (GO:2000188) | 3.68566426 |
| 112 | response to nitrosative stress (GO:0051409) | 3.67228772 |
| 113 | * ketone body metabolic process (GO:1902224) | 3.67132218 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.64622015 |
| 115 | cofactor catabolic process (GO:0051187) | 3.63955277 |
| 116 | acute-phase response (GO:0006953) | 3.62171844 |
| 117 | protein-lipid complex assembly (GO:0065005) | 3.61266473 |
| 118 | protein activation cascade (GO:0072376) | 3.57708083 |
| 119 | monocarboxylic acid catabolic process (GO:0072329) | 3.54859418 |
| 120 | complement activation, classical pathway (GO:0006958) | 3.54375470 |
| 121 | acetyl-CoA metabolic process (GO:0006084) | 3.54087729 |
| 122 | drug metabolic process (GO:0017144) | 3.53926582 |
| 123 | regulation of cholesterol transport (GO:0032374) | 3.50764095 |
| 124 | regulation of sterol transport (GO:0032371) | 3.50764095 |
| 125 | lipoprotein metabolic process (GO:0042157) | 3.47647032 |
| 126 | regulation of lipoprotein particle clearance (GO:0010984) | 3.40078645 |
| 127 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.36766352 |
| 128 | sterol transport (GO:0015918) | 3.36521320 |
| 129 | cholesterol transport (GO:0030301) | 3.36521320 |
| 130 | xenobiotic metabolic process (GO:0006805) | 3.32184030 |
| 131 | negative regulation of lipid transport (GO:0032369) | 3.30280976 |
| 132 | positive regulation of hemostasis (GO:1900048) | 3.28733849 |
| 133 | positive regulation of blood coagulation (GO:0030194) | 3.28733849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.30368963 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13098593 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.77199821 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.41722744 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.20489542 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.16873669 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.99115229 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86378149 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.76844101 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14288595 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07267512 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04804290 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7645139 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58662357 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55057053 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55047394 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39416979 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29672932 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29116381 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29077062 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.20582970 |
| 22 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19244395 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16533956 |
| 24 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15040759 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09896320 |
| 26 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09643229 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09093740 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04825019 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03297748 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02704898 |
| 31 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02540709 |
| 32 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01699203 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98115963 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97892557 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97546866 |
| 36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95989352 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95345063 |
| 38 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89519426 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86469886 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.83194443 |
| 41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82659350 |
| 42 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82311947 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81889091 |
| 44 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81564123 |
| 45 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.80423215 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79048866 |
| 47 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78418976 |
| 48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78261438 |
| 49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78175053 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77097328 |
| 51 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76209797 |
| 52 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75731325 |
| 53 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.74621641 |
| 54 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73909870 |
| 55 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.72366945 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.72148189 |
| 57 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71629250 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70127703 |
| 59 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67719341 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67546941 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.66558568 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.66351618 |
| 63 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65589344 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64637207 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 0.64355915 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63497918 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63497918 |
| 68 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.63272488 |
| 69 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.61555348 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61063093 |
| 71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60949745 |
| 72 | NFYA_21822215_ChIP-Seq_K562_Human | 0.59707099 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.59286972 |
| 74 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59254425 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.59007649 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.58904196 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.58802248 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58609622 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58356153 |
| 80 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.57201917 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.56306740 |
| 82 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55815900 |
| 83 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.55689841 |
| 84 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.55124230 |
| 85 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.55119042 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.54955126 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.54940805 |
| 88 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.54375924 |
| 89 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53221609 |
| 90 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.52210512 |
| 91 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.51933834 |
| 92 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51775083 |
| 93 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.51465059 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.51360984 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51272428 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.51138247 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.50862553 |
| 98 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.50291177 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50281781 |
| 100 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.49945882 |
| 101 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49809022 |
| 102 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.49744680 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.49722146 |
| 104 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.49374101 |
| 105 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49346773 |
| 106 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.49319923 |
| 107 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48256999 |
| 108 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47962601 |
| 109 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47484820 |
| 110 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47275765 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.47058326 |
| 112 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.46947100 |
| 113 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46614911 |
| 114 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46429436 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.46280147 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.45970224 |
| 117 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45783397 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.45637802 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44671354 |
| 120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44370438 |
| 121 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42839542 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41312110 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40955421 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40511261 |
| 125 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40406157 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.38674704 |
| 127 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37480116 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37379332 |
| 129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.37356414 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.37305952 |
| 131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36728491 |
| 132 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.36676661 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36006683 |
| 134 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.35378316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.29012502 |
| 2 | MP0005360_urolithiasis | 7.35234704 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37261866 |
| 4 | MP0005365_abnormal_bile_salt | 6.14867346 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.24165534 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.20913978 |
| 7 | MP0003252_abnormal_bile_duct | 3.89659273 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57261538 |
| 9 | MP0009840_abnormal_foam_cell | 3.25495487 |
| 10 | MP0005083_abnormal_biliary_tract | 3.03874706 |
| 11 | MP0003195_calcinosis | 2.83009208 |
| 12 | MP0005332_abnormal_amino_acid | 2.72545405 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.66093314 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.39848915 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.18896710 |
| 16 | MP0000609_abnormal_liver_physiology | 2.13503967 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09708198 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.00364100 |
| 19 | MP0003868_abnormal_feces_composition | 1.93670039 |
| 20 | MP0001986_abnormal_taste_sensitivity | 1.83574775 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.80915161 |
| 22 | MP0005451_abnormal_body_composition | 1.66875823 |
| 23 | MP0001764_abnormal_homeostasis | 1.59388111 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57074826 |
| 25 | MP0009697_abnormal_copulation | 1.45630595 |
| 26 | MP0003011_delayed_dark_adaptation | 1.35688236 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.33113638 |
| 28 | MP0003186_abnormal_redox_activity | 1.28562470 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.23878253 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.19043686 |
| 31 | MP0005647_abnormal_sex_gland | 1.16590664 |
| 32 | MP0000598_abnormal_liver_morphology | 1.13974553 |
| 33 | MP0005636_abnormal_mineral_homeostasis | 1.03928157 |
| 34 | MP0000604_amyloidosis | 1.03776487 |
| 35 | MP0009764_decreased_sensitivity_to | 1.01201720 |
| 36 | MP0002822_catalepsy | 1.00599716 |
| 37 | MP0002254_reproductive_system_inflammat | 0.99705917 |
| 38 | MP0009763_increased_sensitivity_to | 0.96304223 |
| 39 | MP0003879_abnormal_hair_cell | 0.92896131 |
| 40 | MP0010368_abnormal_lymphatic_system | 0.89710005 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.86249715 |
| 42 | MP0008469_abnormal_protein_level | 0.84984568 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.83815306 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.82423390 |
| 45 | MP0005376_homeostasis/metabolism_phenot | 0.79025798 |
| 46 | MP0005408_hypopigmentation | 0.78555717 |
| 47 | MP0005058_abnormal_lysosome_morphology | 0.78553690 |
| 48 | MP0005670_abnormal_white_adipose | 0.78399862 |
| 49 | MP0009765_abnormal_xenobiotic_induced | 0.76194341 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.75104268 |
| 51 | MP0004130_abnormal_muscle_cell | 0.74756386 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 0.74725070 |
| 53 | MP0001756_abnormal_urination | 0.70807868 |
| 54 | MP0001661_extended_life_span | 0.70061696 |
| 55 | MP0002971_abnormal_brown_adipose | 0.69465857 |
| 56 | MP0000566_synostosis | 0.68874565 |
| 57 | MP0003690_abnormal_glial_cell | 0.68375201 |
| 58 | MP0005334_abnormal_fat_pad | 0.67630303 |
| 59 | MP0005266_abnormal_metabolism | 0.67366237 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 0.65839764 |
| 61 | MP0009053_abnormal_anal_canal | 0.64468764 |
| 62 | MP0005023_abnormal_wound_healing | 0.63885683 |
| 63 | MP0005187_abnormal_penis_morphology | 0.63690501 |
| 64 | MP0005535_abnormal_body_temperature | 0.61879699 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 0.61201870 |
| 66 | MP0003329_amyloid_beta_deposits | 0.59781514 |
| 67 | MP0005448_abnormal_energy_balance | 0.57736380 |
| 68 | MP0000639_abnormal_adrenal_gland | 0.57057267 |
| 69 | MP0000467_abnormal_esophagus_morphology | 0.55882357 |
| 70 | MP0000516_abnormal_urinary_system | 0.53545647 |
| 71 | MP0005367_renal/urinary_system_phenotyp | 0.53545647 |
| 72 | MP0002136_abnormal_kidney_physiology | 0.50824697 |
| 73 | MP0008873_increased_physiological_sensi | 0.47994756 |
| 74 | MP0005167_abnormal_blood-brain_barrier | 0.47933067 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.47195361 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.47177356 |
| 77 | MP0005164_abnormal_response_to | 0.46990259 |
| 78 | MP0005395_other_phenotype | 0.45552935 |
| 79 | MP0005464_abnormal_platelet_physiology | 0.45342245 |
| 80 | MP0001915_intracranial_hemorrhage | 0.45042897 |
| 81 | MP0010386_abnormal_urinary_bladder | 0.44454192 |
| 82 | MP0002928_abnormal_bile_duct | 0.44296877 |
| 83 | MP0003075_altered_response_to | 0.43707405 |
| 84 | MP0003953_abnormal_hormone_level | 0.43311198 |
| 85 | MP0003724_increased_susceptibility_to | 0.42896776 |
| 86 | MP0002837_dystrophic_cardiac_calcinosis | 0.42393889 |
| 87 | MP0002796_impaired_skin_barrier | 0.41960421 |
| 88 | MP0008874_decreased_physiological_sensi | 0.41110475 |
| 89 | MP0005166_decreased_susceptibility_to | 0.41011139 |
| 90 | MP0003941_abnormal_skin_development | 0.40813034 |
| 91 | MP0008872_abnormal_physiological_respon | 0.40414442 |
| 92 | MP0003718_maternal_effect | 0.40240579 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.40157099 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.40126640 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.39950367 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.39926372 |
| 97 | MP0009384_cardiac_valve_regurgitation | 0.38756018 |
| 98 | MP0000477_abnormal_intestine_morphology | 0.36714828 |
| 99 | MP0001663_abnormal_digestive_system | 0.35295486 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.34856663 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.34855710 |
| 102 | MP0003436_decreased_susceptibility_to | 0.34818172 |
| 103 | MP0004883_abnormal_blood_vessel | 0.34763423 |
| 104 | MP0002090_abnormal_vision | 0.34745404 |
| 105 | MP0009780_abnormal_chondrocyte_physiolo | 0.34608217 |
| 106 | MP0000249_abnormal_blood_vessel | 0.34160206 |
| 107 | MP0009115_abnormal_fat_cell | 0.33958387 |
| 108 | MP0002282_abnormal_trachea_morphology | 0.33342487 |
| 109 | MP0010155_abnormal_intestine_physiology | 0.32172858 |
| 110 | MP0009672_abnormal_birth_weight | 0.31229433 |
| 111 | MP0002132_abnormal_respiratory_system | 0.30700016 |
| 112 | MP0000537_abnormal_urethra_morphology | 0.30560204 |
| 113 | MP0002168_other_aberrant_phenotype | 0.29999296 |
| 114 | MP0004043_abnormal_pH_regulation | 0.29965656 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.29920150 |
| 116 | MP0002060_abnormal_skin_morphology | 0.29892455 |
| 117 | MP0000579_abnormal_nail_morphology | 0.29549806 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.29540507 |
| 119 | MP0006082_CNS_inflammation | 0.29084215 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.29048688 |
| 121 | MP0005409_darkened_coat_color | 0.28987181 |
| 122 | MP0001845_abnormal_inflammatory_respons | 0.28936420 |
| 123 | MP0004272_abnormal_basement_membrane | 0.28560285 |
| 124 | MP0001243_abnormal_dermal_layer | 0.28497004 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.27389379 |
| 126 | MP0003567_abnormal_fetal_cardiomyocyte | 0.27319567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.22244419 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.21465076 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.21434551 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.56706416 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.34711044 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.32440403 |
| 7 | Xanthomatosis (HP:0000991) | 6.20490501 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.45118172 |
| 9 | Complement deficiency (HP:0004431) | 4.97253664 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.82206418 |
| 11 | Hyperammonemia (HP:0001987) | 4.71574917 |
| 12 | Joint hemorrhage (HP:0005261) | 4.60449410 |
| 13 | Hyperglycinemia (HP:0002154) | 4.41065887 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.37914878 |
| 15 | Epidermoid cyst (HP:0200040) | 4.35631798 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.28900153 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.25157289 |
| 18 | Ketosis (HP:0001946) | 4.22339115 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.21545045 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21447851 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.10199299 |
| 22 | Hypoglycemic coma (HP:0001325) | 4.09401028 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08008712 |
| 24 | Fat malabsorption (HP:0002630) | 4.05903784 |
| 25 | Hyperglycinuria (HP:0003108) | 3.99380139 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.92175426 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.92175426 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71589759 |
| 29 | Abnormality of complement system (HP:0005339) | 3.63349167 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.62645817 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.60593881 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59354042 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.52989912 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.48807314 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.32073623 |
| 36 | Nephritis (HP:0000123) | 3.26032832 |
| 37 | Ketoacidosis (HP:0001993) | 3.02376850 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01596631 |
| 39 | Steatorrhea (HP:0002570) | 3.01190162 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 2.99873706 |
| 41 | Spontaneous abortion (HP:0005268) | 2.99324194 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.97237838 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.95650002 |
| 44 | Dicarboxylic aciduria (HP:0003215) | 2.92149179 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.92149179 |
| 46 | Metabolic acidosis (HP:0001942) | 2.85532478 |
| 47 | Myocardial infarction (HP:0001658) | 2.84002294 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 2.81766541 |
| 49 | Joint swelling (HP:0001386) | 2.76553560 |
| 50 | Lethargy (HP:0001254) | 2.71795129 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.71072038 |
| 52 | Skin nodule (HP:0200036) | 2.64358892 |
| 53 | Retinal atrophy (HP:0001105) | 2.63120394 |
| 54 | Vascular calcification (HP:0004934) | 2.60725937 |
| 55 | Cerebral edema (HP:0002181) | 2.57539665 |
| 56 | Abnormal delivery (HP:0001787) | 2.56178213 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.54161398 |
| 58 | Acanthocytosis (HP:0001927) | 2.52835467 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.47274971 |
| 60 | Gout (HP:0001997) | 2.46278190 |
| 61 | Osteomalacia (HP:0002749) | 2.43645478 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.40213110 |
| 63 | Spastic diplegia (HP:0001264) | 2.38942752 |
| 64 | Malnutrition (HP:0004395) | 2.38884980 |
| 65 | Glomerulonephritis (HP:0000099) | 2.35676123 |
| 66 | Abnormal gallbladder physiology (HP:0012438) | 2.35607057 |
| 67 | Cholecystitis (HP:0001082) | 2.35607057 |
| 68 | Cholelithiasis (HP:0001081) | 2.35328098 |
| 69 | Sensorimotor neuropathy (HP:0007141) | 2.32063805 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.31483168 |
| 71 | Irritability (HP:0000737) | 2.31223947 |
| 72 | Neonatal onset (HP:0003623) | 2.29640799 |
| 73 | Amyloidosis (HP:0011034) | 2.25670145 |
| 74 | Esophageal varix (HP:0002040) | 2.24878505 |
| 75 | Mitral stenosis (HP:0001718) | 2.23808917 |
| 76 | Pancreatitis (HP:0001733) | 2.18367047 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.18221593 |
| 78 | Hyperactive renin-angiotensin system (HP:0000841) | 2.17572633 |
| 79 | Vomiting (HP:0002013) | 2.15687544 |
| 80 | Gingival bleeding (HP:0000225) | 2.14333863 |
| 81 | Late onset (HP:0003584) | 2.14021749 |
| 82 | Brushfield spots (HP:0001088) | 2.12550401 |
| 83 | Elevated alkaline phosphatase (HP:0003155) | 2.10014758 |
| 84 | Menorrhagia (HP:0000132) | 2.09673822 |
| 85 | Alkalosis (HP:0001948) | 2.09111973 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 2.08065768 |
| 87 | Enlarged kidneys (HP:0000105) | 2.06896523 |
| 88 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06428349 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.05518687 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04934371 |
| 91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04133790 |
| 92 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.03710393 |
| 93 | Epistaxis (HP:0000421) | 2.01058548 |
| 94 | Opisthotonus (HP:0002179) | 2.00573379 |
| 95 | Thrombophlebitis (HP:0004418) | 1.98220689 |
| 96 | Rickets (HP:0002748) | 1.97647937 |
| 97 | Poikilocytosis (HP:0004447) | 1.97409718 |
| 98 | Abnormal tarsal ossification (HP:0008369) | 1.96983837 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 1.96606226 |
| 100 | Cerebral palsy (HP:0100021) | 1.95850119 |
| 101 | Chronic hepatic failure (HP:0100626) | 1.94837802 |
| 102 | Hemorrhage of the eye (HP:0011885) | 1.93971958 |
| 103 | Renal cortical cysts (HP:0000803) | 1.92604786 |
| 104 | Hydroxyprolinuria (HP:0003080) | 1.89292363 |
| 105 | Abnormality of proline metabolism (HP:0010907) | 1.89292363 |
| 106 | Glycosuria (HP:0003076) | 1.86792979 |
| 107 | Abnormality of urine glucose concentration (HP:0011016) | 1.86792979 |
| 108 | Fair hair (HP:0002286) | 1.84326843 |
| 109 | Abnormality of iron homeostasis (HP:0011031) | 1.83080571 |
| 110 | Proximal tubulopathy (HP:0000114) | 1.81567535 |
| 111 | Abnormality of vitamin metabolism (HP:0100508) | 1.80533831 |
| 112 | Neonatal hypoglycemia (HP:0001998) | 1.80061577 |
| 113 | Increased serum pyruvate (HP:0003542) | 1.79809616 |
| 114 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79668404 |
| 115 | Elevated hepatic transaminases (HP:0002910) | 1.79652020 |
| 116 | Hypophosphatemic rickets (HP:0004912) | 1.78538797 |
| 117 | Increased purine levels (HP:0004368) | 1.77037459 |
| 118 | Metabolic alkalosis (HP:0200114) | 1.71836253 |
| 119 | Pulmonary embolism (HP:0002204) | 1.70898953 |
| 120 | Purpura (HP:0000979) | 1.70713821 |
| 121 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.70439955 |
| 122 | Abnormality of alanine metabolism (HP:0010916) | 1.70439955 |
| 123 | Hyperalaninemia (HP:0003348) | 1.70439955 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.69905852 |
| 125 | Reduced antithrombin III activity (HP:0001976) | 1.68775045 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.65845906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 7.98858889 |
| 2 | BCKDK | 7.11606777 |
| 3 | ERN1 | 4.56902909 |
| 4 | SIK1 | 4.24269276 |
| 5 | FGFR4 | 4.12158245 |
| 6 | ACVR1B | 3.82387951 |
| 7 | TAOK3 | 3.20607712 |
| 8 | MST1R | 3.16479168 |
| 9 | INSRR | 2.80545303 |
| 10 | EPHA2 | 2.69165373 |
| 11 | ERBB4 | 2.37540471 |
| 12 | FRK | 2.31781256 |
| 13 | PKN2 | 2.21065456 |
| 14 | MAP2K4 | 2.06588915 |
| 15 | AKT3 | 1.98352608 |
| 16 | PIK3CG | 1.83601591 |
| 17 | LATS1 | 1.79455812 |
| 18 | TYK2 | 1.72779299 |
| 19 | FLT3 | 1.72320130 |
| 20 | MAPK11 | 1.64259661 |
| 21 | TRIB3 | 1.61762374 |
| 22 | WNK3 | 1.57701562 |
| 23 | PTK6 | 1.53674538 |
| 24 | ABL2 | 1.49934090 |
| 25 | MAP3K12 | 1.45021586 |
| 26 | NEK9 | 1.40807593 |
| 27 | DAPK2 | 1.35495394 |
| 28 | MAP3K7 | 1.32259571 |
| 29 | KDR | 1.30429222 |
| 30 | OXSR1 | 1.30285891 |
| 31 | WNK4 | 1.23977882 |
| 32 | PIK3CA | 1.21094826 |
| 33 | MET | 1.20223694 |
| 34 | FGFR2 | 1.15513003 |
| 35 | STK39 | 1.12394086 |
| 36 | TBK1 | 1.10924720 |
| 37 | JAK2 | 1.10674838 |
| 38 | PRKAA2 | 1.08987602 |
| 39 | GRK6 | 1.05353386 |
| 40 | MAP3K14 | 1.03414391 |
| 41 | EPHB1 | 1.01238017 |
| 42 | ERBB2 | 1.00849441 |
| 43 | MAP2K2 | 0.98185555 |
| 44 | MAP2K6 | 0.93592773 |
| 45 | FER | 0.92752935 |
| 46 | PINK1 | 0.90962645 |
| 47 | CAMK1D | 0.90212399 |
| 48 | MAPK4 | 0.89104284 |
| 49 | MAPK15 | 0.88071783 |
| 50 | RIPK1 | 0.87477837 |
| 51 | TIE1 | 0.87134813 |
| 52 | CSK | 0.87087829 |
| 53 | JAK1 | 0.86581878 |
| 54 | NTRK3 | 0.83524333 |
| 55 | PRKCZ | 0.82807159 |
| 56 | MAP2K3 | 0.80728194 |
| 57 | MAP3K10 | 0.80458434 |
| 58 | NLK | 0.76530619 |
| 59 | CDK6 | 0.75855115 |
| 60 | MAP3K11 | 0.75703539 |
| 61 | PRKACG | 0.74938294 |
| 62 | STK38L | 0.74170763 |
| 63 | NEK1 | 0.72491022 |
| 64 | CASK | 0.72188107 |
| 65 | DYRK1B | 0.70482523 |
| 66 | CAMK2G | 0.70307314 |
| 67 | MAPKAPK3 | 0.69128229 |
| 68 | EIF2AK3 | 0.68982036 |
| 69 | MAPK12 | 0.68718974 |
| 70 | MAP3K3 | 0.65876556 |
| 71 | GSK3A | 0.62454843 |
| 72 | PRKAA1 | 0.62373031 |
| 73 | MAP2K1 | 0.62215252 |
| 74 | PTK2 | 0.58972893 |
| 75 | IKBKE | 0.57997831 |
| 76 | PDPK1 | 0.56751269 |
| 77 | PRKG1 | 0.55872158 |
| 78 | PRKACB | 0.54994842 |
| 79 | EPHA3 | 0.53942122 |
| 80 | TGFBR2 | 0.52591891 |
| 81 | PRKCQ | 0.51714897 |
| 82 | MAP3K2 | 0.51356045 |
| 83 | ICK | 0.51099967 |
| 84 | GRK1 | 0.50920940 |
| 85 | MYLK | 0.50084058 |
| 86 | CSNK1A1 | 0.49943061 |
| 87 | IRAK3 | 0.49196975 |
| 88 | SGK3 | 0.48493140 |
| 89 | PRKCE | 0.48202185 |
| 90 | PRKCB | 0.47857381 |
| 91 | CAMK2D | 0.46491550 |
| 92 | CSNK1E | 0.46153384 |
| 93 | PHKG2 | 0.45478264 |
| 94 | PHKG1 | 0.45478264 |
| 95 | NUAK1 | 0.45236125 |
| 96 | MAPK7 | 0.45187594 |
| 97 | CSF1R | 0.44096125 |
| 98 | PDGFRA | 0.43542865 |
| 99 | TAOK2 | 0.43352125 |
| 100 | TNK2 | 0.42764900 |
| 101 | PRKACA | 0.41973056 |
| 102 | MAP3K1 | 0.40404413 |
| 103 | RET | 0.39743879 |
| 104 | NEK6 | 0.39447655 |
| 105 | EPHB2 | 0.38993685 |
| 106 | CSNK1D | 0.38898933 |
| 107 | KSR2 | 0.38742516 |
| 108 | IGF1R | 0.38615221 |
| 109 | FGFR3 | 0.38294515 |
| 110 | PDK1 | 0.37081661 |
| 111 | CAMK1G | 0.35832139 |
| 112 | PRKCA | 0.35721151 |
| 113 | PDK3 | 0.35494264 |
| 114 | PDK4 | 0.35494264 |
| 115 | CDK9 | 0.34285353 |
| 116 | MAP3K5 | 0.34071105 |
| 117 | AKT2 | 0.33799930 |
| 118 | TESK2 | 0.32179356 |
| 119 | SRC | 0.31969291 |
| 120 | EPHA4 | 0.31682327 |
| 121 | CSNK2A2 | 0.31608895 |
| 122 | CSNK1G1 | 0.31281735 |
| 123 | RPS6KB1 | 0.30419334 |
| 124 | OBSCN | 0.30141211 |
| 125 | EGFR | 0.29534605 |
| 126 | MTOR | 0.29400888 |
| 127 | SGK2 | 0.29336899 |
| 128 | PBK | 0.29197553 |
| 129 | LMTK2 | 0.28819137 |
| 130 | PRKCG | 0.28686346 |
| 131 | SGK494 | 0.28269959 |
| 132 | SGK223 | 0.28269959 |
| 133 | PRPF4B | 0.26889708 |
| 134 | PRKG2 | 0.26709556 |
| 135 | CDK4 | 0.25066932 |
| 136 | PRKCI | 0.24441005 |
| 137 | MATK | 0.23922164 |
| 138 | CAMK4 | 0.21140616 |
| 139 | PAK3 | 0.21081582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31327153 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.49784149 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49738873 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.16220274 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91446370 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73322358 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67072686 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65038644 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63031811 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.59798769 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46652347 |
| 12 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41769432 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39605867 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.22076895 |
| 15 | * Butanoate metabolism_Homo sapiens_hsa00650 | 2.11084229 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.08031452 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.06225250 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.02539218 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00073262 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99222941 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98873674 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91939551 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.89441987 |
| 24 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84489051 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76326077 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73213987 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71398024 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63894736 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63742233 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62259310 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.55746159 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54635949 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52857727 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50962210 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44261794 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42694833 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42458154 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41234606 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40450517 |
| 40 | * Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33563315 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31417579 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29025174 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28803138 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25428133 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.19231243 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.17968039 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16135567 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12976527 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09503202 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01727929 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99954567 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94512211 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93925462 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93834905 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91724144 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85664263 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85236451 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82994671 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.77715146 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75393516 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73781975 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67130119 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66812375 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65531915 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54293229 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52820319 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48821947 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45384769 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.45331435 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43877982 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38954081 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37721329 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28458986 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.28354370 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21794012 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20300036 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.20161907 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19650589 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13917738 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.09260307 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06509200 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.02759193 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01188625 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00590456 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2128946 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | -0.2093735 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | -0.2045922 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1914848 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1892136 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1889428 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1810259 |
| 92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1787357 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1772817 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1714087 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1687976 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1678247 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1666979 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1644446 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1607323 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1575891 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.1518931 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1465887 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | -0.1427091 |
| 104 | Tight junction_Homo sapiens_hsa04530 | -0.1389613 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1293861 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | -0.1144280 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1056950 |
| 108 | * Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1050018 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0810460 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0729743 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0315620 |

